Molecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers.
AffiliationPathology Service, Massachusetts General Hospital, Boston, MA 02114, USA.
Tumor Markers, Biological
MetadataShow full item record
CitationMolecular pathology in adult gliomas: diagnostic, prognostic, and predictive markers. 2010, 9 (7):717-26 Lancet Neurol
AbstractOver the past 10 years, there has been an increasing use of molecular markers in the assessment and management of adult malignant gliomas. Some molecular signatures are used diagnostically to help pathologists classify tumours, whereas others are used to estimate prognosis for patients. Most crucial, however, are those markers that are used to predict response to certain therapies, thereby directing clinicians to a particular treatment while avoiding other potentially deleterious therapies. Recently, large-scale genome-wide surveys have been used to identify new biomarkers that have been rapidly developed as diagnostic and prognostic tools. Given these developments, the pace of discovery of new molecular assays will quicken to facilitate personalised medicine in the setting of malignant glioma.
- Molecular markers of glioma: an update on recent progress and perspectives.
- Authors: Gupta K, Salunke P
- Issue date: 2012 Dec
- Molecular diagnostics of gliomas: the clinical perspective.
- Authors: Tabatabai G, Stupp R, van den Bent MJ, Hegi ME, Tonn JC, Wick W, Weller M
- Issue date: 2010 Nov
- Progress on molecular biomarkers and classification of malignant gliomas.
- Authors: Zhang C, Bao Z, Zhang W, Jiang T
- Issue date: 2013 Jun
- Diagnostic, prognostic and predictive relevance of molecular markers in gliomas.
- Authors: Brandner S, von Deimling A
- Issue date: 2015 Oct
- The prognostic value of clinical factors and cancer stem cell-related markers in gliomas.
- Authors: Dahlrot RH
- Issue date: 2014 Oct